SlideShare uma empresa Scribd logo
1 de 116
By
SUNILBOREDDY
M.Pharmacy
 Certain pharmaceutical products must be sterile
◦ injections, ophthalmic preparations, irrigations solutions,
haemodialysis solutions
 Two categories of sterile products
◦ those that can be sterilized in final container (terminally
sterilized)
◦ those that cannot be terminally sterilized and must be
aseptically prepared
Aseptic processing
 Objective is to maintain the sterility of a product,
assembled from sterile components
 Operating conditions so as to prevent microbial
contamination
Objective
 To review specific issues relating to the manufacture of
aseptically prepared products:
◦ Manufacturing environment
 Clean areas
 Personnel
◦ Preparation and filtration of solutions
◦ Pre-filtration bioburden
◦ Filter integrity/validation
◦ Equipment/container preparation and sterilization
◦ Filling Process
◦ Validation of aseptic processes
◦ Specific issues relating to Isolators, BFS and Bulk
Classification of Clean Areas
◦ Comparison of classifications
WHO GMP US 209E US Customary ISO/TC (209)
ISO 14644
EEC GMP
Grade A M 3.5 Class 100 ISO 5 Grade A
Grade B M 3.5 Class 100 ISO 5 Grade B
Grade C M 5.5 Class 10 000 ISO 7 Grade C
Grade D M 6.5 Class 100 000 ISO 8 Grade D
Table 1
Classification of Clean Areas
◦ Classified in terms of airborne particles (Table 2)
Grade At rest In operation
maximum permitted number of particles/m3
0.5 - 5.0 µm > 5 µm 0.5 - 5.0 µm > 5 µ
A 3 500 0 3 500 0
B 3 500 0 350 000 2 000
C 350 000 2 000 3 500 000 20 000
D 3 500 000 20 000 not defined not defined
“At rest” - production equipment installed and operating
“In operation” - Installed equipment functioning in defined
operating mode and specified number of personnel present
Four grades of clean areas:
 Grade D (equivalent to Class 100,000, ISO 8):
◦ Clean area for carrying out less critical stages in manufacture
of aseptically prepared products eg. handling of components
after washing.
 Grade C (equivalent to Class 10,000, ISO 7):
◦ Clean area for carrying out less critical stages in manufacture
of aseptically prepared products eg. preparation of solutions
to be filtered.
 Grade B (equivalent to Class 100, ISO 5):
◦ Background environment for Grade A zone, eg. cleanroom in
which laminar flow workstation is housed.
 Grade A (equivalent to Class 100 (US Federal Standard
209E), ISO 5 (ISO 14644-1):
◦ Local zone for high risk operations eg. product filling, stopper
bowls, open vials, handling sterile materials, aseptic connections,
transfer of partially stoppered containers to be lyophilized.
◦ Conditions usually provided by laminar air flow workstation.
 Each grade of cleanroom has specifications for viable
and non-viable particles
◦ Non-viable particles are defined by the air classification (See
Table 2)
 Limits for viable particles (microbiological
contamination)
Grade Air sample
(CFU/m3)
Settle plates (90mm
diameter)
(CFU/4hours)
Contact plates
(55mm
diameter)
(CFU/plate)
Glove print
(5 fingers)
(CFU/glove)
A < 3 < 3 < 3 < 3
B 10 5 5 5
C 100 50 25 -
D 200 100 50 -
Table 3
– These are average values
– Individual settle plates may be exposed for less than 4 hours
• Values are for guidance only - not intended to represent specifications
• Levels (limits) of detection of microbiological contamination should be
established for alert and action purposes and for monitoring trends of
air quality in the facility
Environmental Monitoring
 Physical
◦ Particulate matter
◦ Differential pressures
◦ Air changes, airflow patterns
◦ Clean up time/recovery
◦ Temperature and relative humidity
◦ Airflow velocity
Environmental Monitoring - Physical
 Particulate matter
◦ Particles significant because they can contaminate and also carry
organisms
◦ Critical environment should be measured not more than 30cm
from worksite, within airflow and during filling/closing operations
◦ Preferably a remote probe that monitors continuously
◦ Difficulties when process itself generates particles (e.g. powder
filling)
◦ Appropriate alert and action limits should be set and corrective
actions defined if limits exceeded
Environmental Monitoring - Physical
 Differential pressures
◦ Positive pressure differential of 10-15 Pascals should be
maintained between adjacent rooms of different classification
(with door closed)
◦ Most critical area should have the highest pressure
◦ Pressures should be continuously monitored and frequently
recorded.
◦ Alarms should sound if pressures deviate
◦ Any deviations should be investigated and effect on
environmental quality determined
Environmental Monitoring - Physical
 Air Changes/Airflow patterns
◦ Air flow over critical areas should be uni-directional (laminar
flow) at a velocity sufficient to sweep particles away from
filling/closing area
◦ for B, C and D rooms at least 20 changes per hour are
ususally required
 Clean up time/recovery
◦ Particulate levels for the Grade A “at rest” state should be
achieved after a short “clean-up” period of 20 minutes after
completion of operations (guidance value)
◦ Particle counts for Grade A “in operation” state should be
maintained whenever product or open container is exposed
Environmental Monitoring - Physical
 Temperature and Relative Humidity
◦ Ambient temperature and humidity should not be
uncomfortably high (could cause operators to generate
particles) (18°C)
 Airflow velocity
◦ Laminar airflow workstation air speed of approx 0.45m/s ±
20% at working position (guidance value)
Personnel
 Minimum number of personnel in clean areas
◦ especially during aseptic processing
 Inspections and controls from outside
 Training to all including cleaning and maintenance staff
◦ initial and regular
◦ manufacturing, hygiene, microbiology
◦ should be formally validated and authorized to enter aseptic area
 Special cases
◦ supervision in case of outside staff
◦ decontamination procedures (e.g. staff who worked with animal
tissue materials)
Personnel (2)
 High standards of hygiene and cleanliness
◦ should not enter clean rooms if ill or with open wounds
 Periodic health checks
 No shedding of particles, movement slow and
controlled
 No introduction of microbiological hazards
 No outdoor clothing brought into clean areas, should be
clad in factory clothing
 Changing and washing procedure
 No watches, jewellery and cosmetics
 Eye checks if involved in visual inspection
Personnel (3)
 Clothing of appropriate quality:
◦ Grade D
 hair, beard, moustache covered
 protective clothing and shoes
◦ Grade C
 hair, beard, moustache covered
 single or 2-piece suit (covering wrists, high neck),
shoes/overshoes
 no fibres/particles to be shed
◦ Grade A and B
 headgear, beard and moustache covered, masks,
gloves
 not shedding fibres, and retain particles shed by
operators
Personnel (4)
 Outdoor clothing not in change rooms leading to Grade B
and C rooms
 Change at every working session, or once a day (if
supportive data)
 Change gloves and masks at every working session
 Frequent disinfection of gloves during operations
 Washing of garments – separate laundry facility
◦ No damage, and according to validated procedures
(washing and sterilization)
 Regular microbiological monitoring of operators
 In aseptic processing, each component is individually
sterilised, or several components are combined with
the resulting mixture sterilized.
◦ Most common is preparation of a solution which is filtered
through a sterilizing filter then filled into sterile containers (e.g
active and excipients dissolved in Water for Injection)
◦ May involve aseptic compounding of previously sterilized
components which is filled into sterile containers
◦ May involve filling of previously sterilized powder
 sterilized by dry heat/irradiation
 produced from a sterile filtered solution which is then aseptically
crystallized and precipitated
 requires more handling and manipulation with higher potential for
contamination during processing
Preparation and Filtration of Solutions
 Solutions to be sterile filtered prepared in a Grade C
environment
 If not to be filtered, preparation should be prepared in a
Grade A environment with Grade B background (e.g.
ointments, creams, suspensions and emulsions)
 Prepared solutions filtered through a sterile 0.22μm (or
less) membrane filter into a previously sterilized container
◦ filters remove bacteria and moulds
◦ do not remove all viruses or mycoplasmas
 filtration should be carried out under positive pressure
Preparation and Filtration of Solutions (2)
 consideration should be given to complementing filtration
process with some form of heat treatment
 Double filter or second filter at point of fill advisable
 Fitlers should not shed particles, asbestos containing
filters should not be used
 Same filter should not be used for more than one day
unless validated
 If bulk product is stored in sealed vessels, pressure
release outlets should have hydrophobic microbial
retentive air filters
Preparation and Filtration of Solutions (3)
 Time limits should be established for each phase of processing, e.g.
◦ maximum period between start of bulk product compounding and
sterilization (filtration)
◦ maximum permitted holding time of bulk if held after filtration prior to filling
◦ product exposure on processing line
◦ storage of sterilized containers/components
◦ total time for product filtration to prevent organisms from penetrating filter
◦ maximum time for upstream filters used for clarification or particle removal
(can support microbial attachment)
Preparation and Filtration of Solutions (4)
 Filling of solution may be followed by lyophilization (freeze
drying)
◦ stoppers partially seated, product transferred to lyophilizer (Grade
A/B conditions)
◦ Release of air/nitrogen into lyophilizer chamber at completion of
process should be through sterilizing filter
Prefiltration Bioburden (natural microbial load)
 Limits should be stated and testing should be carried out on
each batch
 Frequency may be reduced after satisfactory history is
established
◦ and biobuden testing performed on components
 Should include action and alert limits (usually differ by a factor
of 10) and action taken if limits are exceeded
 Limits should reasonably reflect bioburden routinely achieved
Prefiltation Bioburden (2)
 No defined “maximum” limit but the limit should not exceed
the validated retention capability of the filter
 Bioburden controls should also be included in “in-process”
controls
◦ particularly when product supports microbial growth and/or
manufacturing process involves use of culture media
 Excessive bioburden can have adverse effect on the quality
of the product and cause excessive levels of
endotoxins/pyrogens
Filter integrity
 Filters of 0.22μm or less should be used for filtration of
liquids and gasses (if applicable)
◦ filters for gasses that may be used for purging or overlaying of
filled containers or to release vacuum in lyphilization chamber
 filter intergrity shoud be verified before filtration and confirmed
after filtration
◦ bubble point
◦ pressure hold
◦ forward flow
 methods are defined by filter manufacturers and limits
determined during filter validation
Equipment/container preparation and sterilization
 All equipment (including lyophilizers) and product
containers/closures should be sterilized using
validated cycles
◦ same requirements apply for equipment sterilization that apply
to terminally sterilized product
◦ particular attention to stoppers - should not be tightly packed
as may clump together and affect air removal during vacuum
stage of sterilization process
◦ equipment wrapped and loaded to facilitate air removal
◦ particular attention to filters, housings and tubing
Equipment/container preparation and sterilization
(2)
 CIP/SIP processes
◦ particular attention to deadlegs - different orientation
requirements for CIP and SIP
 heat tunnels often used for
sterilization/depyrogenation of glass vials/bottles
◦ usually high temperature for short period of time
◦ need to consider speed of conveyor
◦ validation of depyrogenation (3 logs endotoxin units)
 worst case locations
◦ tunnel supplied with HEPA filtered air
Equipment/container preparation and sterilization (2)
 equipment should be designed to be easily assembled and disassembled,
cleaned, sanitised and/or sterilized
◦ equipment should be appropriately cleaned - O-rings and gaskets should be
removed to prevent build up of dirt or residues
 rinse water should be WFI grade
 equipment should be left dry unless sterilized immediately after cleaning (to
prevent build up of pyrogens)
 washing of glass containers and rubber stoppers should be validated for
endotoxin removal
 should be defined storage period between sterilization and use (period
should be justified)
Additional issues specific to Isolator and BFS
Technologies
 Isolators
◦ Decontamination process requires a 4-6 log reduction of
appropriate Biological Indicator (BI)
◦ Minimum 6 log reduction of BI if surface is to be free of
viable organisms
◦ Significant focus on glove integrity - daily checks, second
pair of gloves inside isolator glove
◦ Traditional aseptic vigilance should be maintained
 Blow-Fill-Seal (BFS)
◦ Located in a Grade D environment
◦ Critial zone should meet Grade A (microbiological)
requirements (particle count requirements may be difficult
to meet in operation)
◦ Operators meet Grade C garment requirements
◦ Validation of extrusion process should demonstrate
destruction of endotoxin and spore challenges in the
polymeric material
◦ Final inspection should be capable of detecting leakers
 Issues relating to Aseptic Bulk Processing
• Applies to products which can not be filtered at point of fill and
require aseptic processing throughout entire manufacturing
process.
• Entire aseptic process should be subject to process simulation
studies under worst case conditions (maximum duration of "open"
operations, maximum no of operators)
• Process simulations should incorporate storage and transport of
bulk.
• Multiple uses of the same bulk with storage in between should
also be included in process simulations
• Assurance of bulk vessel integrity for specified holding times.
 Bulk Processing (2)
• Process simulation for formulation stage should be
performed at least twice per year.
◦ Cellular therapies, cell derived products etc
 products released before results of sterility tests known (also
TPNs, radioactive preps, cytotoxics)
 should be manufactured in a closed system
 Additional testing
 sterility testing of intermediates
 microscopic examination (e.g. gram stain)
 endotoxin testing
Environmental MonitoringEnvironmental Monitoring
ConsiderationsConsiderations
 Airborne nonviable particulate monitoring
 Airborne viable contaminant monitoring
 Viable contaminant monitoring of surfaces
 Viable contaminant monitoring of personnel
 Temperature and humidity monitoring
 Pressure differential monitoring
Environmental MonitoringEnvironmental Monitoring
ComponentsComponents
 Water monitoring:
◦ Total organic carbon
◦ Conductivity
◦ Microbial Contaminants
◦ Endotoxin
Environmental MonitoringEnvironmental Monitoring
ComponentsComponents
 Monitoring frequencies and strategies
◦ Establishment of a meaningful and manageable program
 Sampling and testing procedures
 Establishment of effective alert and action limits
 Trending of results
General EnvironmentalGeneral Environmental
Monitoring ConsiderationsMonitoring Considerations
 Investigation and evaluation of trends as well as
excursions from alert and action limits
 Corrective actions to be implemented in response
to environmental monitoring excursions
 Personnel training - sampling, testing,
investigating excursions, aseptic technique
General EnvironmentalGeneral Environmental
Monitoring ConsiderationsMonitoring Considerations
 Should include monitoring of all environments
where products and their components are
manufactured
◦ All areas where there is a risk of product
contamination
 Should include monitoring of all water used for
product manufacturing as well as feed water to the
final water purification system (WFI System)
Scope of EnvironmentalScope of Environmental
Monitoring ProgramMonitoring Program
 CFR GMP regulations
 FDA Guidance Documents
 USP Informational Chapter
Regulatory Basis forRegulatory Basis for
Environmental MonitoringEnvironmental Monitoring
ProgramProgram
 Aseptic processing areas:
◦ Easy to clean and maintain
◦ Temperature and humidity controlled
◦ HEPA filtered air
◦ Environmental monitoring system
◦ Cleaning and disinfecting procedures
◦ Scheduled equipment maintenance and calibration
21 CFR 211.4221 CFR 211.42
 Ventilation, air filtration, air heating and cooling:
◦ Adequate control over microorganisms, dust, humidity
and temperature.
◦ Air filtration systems including prefilters and particulate
matter air filters for air supplies to production areas.
21 CFR 211.4621 CFR 211.46
 Defines critical and controlled manufacturing
areas
 Recommends airborne nonviable and viable
contaminant limits
 Provides some guidance on monitoring
frequencies for critical areas
Guideline on Sterile DrugGuideline on Sterile Drug
Products Produced by AsepticProducts Produced by Aseptic
ProcessingProcessing
 Recommendations for air pressure differentials
 Includes guidance on aseptic media fills
 Note: This guidance document was written in
1987 and is in need of revision
Guideline on Sterile DrugGuideline on Sterile Drug
Products Produced by AsepticProducts Produced by Aseptic
ProcessingProcessing
 USP General Information Chapter <1116>
 Establishment of clean room classifications
◦ Federal Standard 209E
 Importance of EM program
 Personnel training in aseptic processing
 Establishment of sampling plans and sites
◦ suggested sampling frequencies
Microbial Evaluation andMicrobial Evaluation and
Classification of Clean Rooms andClassification of Clean Rooms and
Clean ZonesClean Zones
 Establishment of alert and action limits
 Suggests limits for airborne, surface and
personnel contaminant levels.
 Methods and equipment for sampling
 Identification of isolates
 Aseptic media fills
 Emerging technologies - barrier; isolator
Microbial Evaluation andMicrobial Evaluation and
Classification of Clean Rooms andClassification of Clean Rooms and
Clean ZonesClean Zones
 “Airborne Particulate Cleanliness Classes in Clean
Rooms and Clean Zones
 Approved by the GSA for use by all Federal
Agencies
 Frequently referenced for controlled environment
particulate requirements: Classes 100, 10,000 and
100,000 (based on particles > 0.5µ)
Federal Standard 209EFederal Standard 209E
 Scope limited to final drug product
manufacturing and data required for application
submission (NDA, BLA)
 Requests information on:
◦ Buildings and facilities
◦ Manufacturing operations for drug product
 Filter validation
 Validation of hold times
Guidance for Industry for Sterile ValidationGuidance for Industry for Sterile Validation
Process Validation in Applications for HumanProcess Validation in Applications for Human
and Veterinary Drug Productsand Veterinary Drug Products
 Requests information on:
◦ Sterilization and depyrogenation
◦ Media fills and actions taken when they fail
◦ Microbiological monitoring of the environment
 Airborne microorganisms, personnel, surfaces, water
system, product component bioburden
◦ Yeasts, molds, anaerobes
◦ Exceeded EM limits
Guidance for Industry for Sterile ValidationGuidance for Industry for Sterile Validation
Process Validation in Applications for HumanProcess Validation in Applications for Human
and Veterinary Drug Productsand Veterinary Drug Products
Viable and NonviableViable and Nonviable
Contaminant LimitsContaminant Limits
Classifi-
cation
Nonviable (>0.5µ) Viable
ft3
m3
ft3
m3
Class
100
100 3,530 0.1 3.5
Class
10,000
10,000 353,000 0.5 18
Class
100,000
100,000 3,530,000 2.5 88
 Preparation or manufacturing area where
nonsterile product, in-process materials and
product-contact equipment surfaces, containers
and closures are exposed to the environment
 Control nonviable and viable contaminants to
reduce product /process bioburden
 Class 100,000 or Class 10,000
Controlled AreaControlled Area
 Capping areas are now considered controlled
manufacturing areas
◦ Should be supplied with HEPA filtered air
◦ Should meet class 100,000 conditions during static
conditions
Controlled AreaControlled Area
 Aseptic processing area where sterile products,
components or in-process products are exposed
to the environment and no further processing will
occur.
 Air quality must be Class 100 during processing
 Local Class 100 areas are often utilized during
open processing steps during drug substance
manufacture.
Critical AreaCritical Area
 The area just preceding the sterile core should be
one classification higher than the core.
Critical AreaCritical Area
 Airborne cleanliness classifications should be met
during operations
 Nonviable monitoring should occur routinely
during operations
 Monitoring during static conditions is done as part
of HVAC qualification and may be done
periodically after that to insure area meets
acceptable conditions before use or following
cleaning
Nonviable Particulate MonitoringNonviable Particulate Monitoring
 Locations for monitoring should be established
during performance qualification; probes placed
close to work surface
 Monitoring frequencies vary:
◦ For aseptic processing areas, during each use
◦ For other, controlled areas, varies from each use to
weekly or less depending on use of area
Nonviable Particulate MonitoringNonviable Particulate Monitoring
 HVAC Validation and Maintenance
Considerations:
◦ Air velocity, airflow patterns and turbulence should be
validated; smoke studies to determine flow patterns
during static and dynamic conditions
◦ HEPA filter integrity testing
◦ HEPA filter efficiency testing
◦ Air pressure differentials
Nonviable Particulate MonitoringNonviable Particulate Monitoring
 Airborne viable contaminants
 Surface contaminants
◦ walls
◦ equipment surfaces
◦ countertops
◦ floors
 Personnel contaminants
Microbial MonitoringMicrobial Monitoring
 Monitoring methods should be capable of
detecting molds and yeasts
 Should also be able to detect anaerobes
◦ Most often, this is an issue associated with products filled
anaerobically (with nitrogen overlay)
 All lots of media for EM sampling should be
growth promotion tested
Microbial MonitoringMicrobial Monitoring
 Routine microbial monitoring should take place
during operations (for airborne contaminants) and
immediately following operations (for surfaces and
personnel).
 Airborne monitoring frequencies:
◦ Each use for aseptic processing areas
◦ Varies from daily to weekly to less frequently for
controlled areas depending on use
Microbial MonitoringMicrobial Monitoring
 Personnel and surface monitoring frequencies
vary:
◦ Aseptic processing - after every fill
◦ Other controlled areas - varies from daily to weekly or
less for surfaces
◦ Personnel monitoring often restricted to aseptic area
personnel and personnel working in Class 100 hoods
performing tasks such as inoculation
Microbial MonitoringMicrobial Monitoring
 Monitoring of surfaces and airborne contaminants
during rest periods (following cleaning)
◦ Important for confirming adequacy of cleaning
procedures
◦ Indicates whether HVAC system is operating properly
◦ NOTE: Disinfectant effectiveness studies also required
for cleaning agents used in the facility
Microbial MonitoringMicrobial Monitoring
 Monitoring frequencies and procedures are
influenced by a number of factors:
◦ Stage of manufacturing
◦ “Open” or “closed” manufacturing step
◦ Single or multiple product manufacturing
Microbial MonitoringMicrobial Monitoring
 Establishment of monitoring locations should be
based on performance qualification studies during
dynamic conditions
◦ gridding study to determine worst case locations/most
meaningful locations
 Should also establish common flora - will aid in
investigations
Microbial MonitoringMicrobial Monitoring
 Action limits (for the most part) have been
established in a variety of guidance documents
 Alert limits
◦ Lower than action limits
◦ Reflect actual historical results under normal processing
conditions
Setting Alert and ActionSetting Alert and Action
LimitsLimits
 Alert limits are designed to provide some warning
that environmental quality is approaching action
limit and allow you time to correct.
 Exceeding alert limit triggers a warning response -
i.e., alert affected area personnel
 Exceeding multiple alerts - triggers action level
response
Exceeding LimitsExceeding Limits
 Action limit excursions require investigations
◦ Speciation of organism(s)
◦ Review batch records from date of excursion
◦ Review other recent EM data (trends)
◦ Review cleaning records
◦ Interview personnel
◦ Product impact - must quarantine until determined
Exceeding LimitsExceeding Limits
 Excursions from action limits require corrective
actions that may include:
◦ More rigorous or additional monitoring
◦ More rigorous cleaning
◦ Retraining of personnel
◦ Procedural changes - change to or addition of
disinfection procedures, for example
◦ HVAC maintenance
Exceeding LimitsExceeding Limits
 The investigation procedures to be followed
should be pre-established and included in SOPs
 Depending on the outcome of the investigation,
corrective actions should be pre-established to the
extent possible
Investigations and CorrectiveInvestigations and Corrective
ActionsActions
 Imperative that EM results be linked to product
release so that affected products are not released
until investigation completed
 Material Review Board or equivalent should be
consulted prior to releasing product that was
potentially affected by adverse environmental
conditions
Investigations and CorrectiveInvestigations and Corrective
ActionsActions
 Should trend monitoring results (environmental
and water)
◦ Periodic (quarterly or monthly) review by QA and others
◦ Re-evaluation of action and alert limits on an annual
basis
◦ This trending information is generally included in the
Annual Product Review
TrendingTrending
 Control of temperature and humidity required for
aseptic processing areas
◦ 21 CFR 211.42(c)(10)(ii)
 Generally 65°F and 35-50% humidity are average
◦ Too high - Increases personnel shedding
◦ Too low - Increase static electricity
Temperature and HumidityTemperature and Humidity
 Temperature should be controlled throughout all
manufacturing areas
 Temperature and humidity should be monitored
and controlled in warehouse areas where
temperature/humidity sensitive raw materials are
stored
◦ If not able to control humidity, need procedure to follow if
humidity exceeds limit
Temperature and HumidityTemperature and Humidity
Water RequirementsWater Requirements
Test Potable
Water
Purified
Water
WFI
TOC none 500 ppb 500 ppb
Conduc-
tivity
none See USP Table
Micro.
Purity
500
CFU/ml
100
CFU/ml
10 CFU/
100 ml
Endo-
Toxin
none none 0.25
EU/ml
 Water purified by distillation or reverse osmosis
 Prepared from water complying with the U.S. EPA
National Primary Drinking Water Regulations
 Contains no added substance
Water For InjectionWater For Injection
 Obtained by a suitable process, usually one of the
following:
◦ deionization
◦ reverse osmosis
◦ combination
Purified WaterPurified Water
 Meets National Drinking Water Regulations
 40 CFR Part 141
 Periodic monitoring in-house as well as periodic
certificates from municipality (if applicable)
Potable WaterPotable Water
 WFI Systems
◦ Microbial quality and endotoxin
 Daily system monitoring
 Each use point at least weekly
◦ TOC and Conductivity
 Weekly system monitoring
 can be taken from worst case point (end of loop, return to
tank)
Water System MonitoringWater System Monitoring
 Purified Water Systems
◦ Weekly monitoring of system for:
 microbial quality
 TOC
 conductivity
Water System MonitoringWater System Monitoring
 WFI
◦ Solvent for preparation of parenteral solutions
◦ Formulation of mammalian cell culture media
◦ Formulation of purification buffers
◦ Final product formulation
◦ Vial and stopper washing
◦ Final rinse for product equipment
Water UseWater Use
 Purified Water
◦ Preparation of terminally sterilized microbiological media
◦ Initial rinsing/cleaning
◦ Laboratory use
◦ Feed for WFI system
Water UseWater Use
 Potable Water
◦ Non-product contact uses
◦ Feed for purified water system
Water UseWater Use
 Slit-to-Agar (STA) - Powered by vacuum, air
taken in through a slit below which is a slowly
revolving plate.
 Sieve impactor - Vacuum draws in air through
perforated cover which is impacted onto petri dish
containing nutrient agar
Microbial Monitoring DevicesMicrobial Monitoring Devices
 Centrifugal Sampler - consists of a propeller
that pulls a known volume of air into the unit and
then propels the air outward to impact on a
nutrient agar strip
 Sterilizable Microbiological Atrium (SMA)-
similar to sieve impactor; cover contains uniformly
spaced orifices; vacuum draws in air which is
impacted on agar plate
Microbial Monitoring DevicesMicrobial Monitoring Devices
 Surface Air System Sampler - An integrated
unit containing an entry section with an agar
contact plate; behind is a motor and turbine that
pulls air in through the perforated cover and
exhausts it beyond the motor.
 Settle plates - qualitative; may be useful in worst
case locations
Microbial Monitoring DevicesMicrobial Monitoring Devices
 Surface contaminant monitoring devices:
◦ Contact Plates - plates filled with nutrient agar; for
regular surfaces
◦ Swabs - useful for hard to reach or irregular surfaces;
swab placed in suitable diluent and inoculated onto
microbiological plate
Microbial Monitoring DevicesMicrobial Monitoring Devices
 Remote sampling probes - validate use of tubing
 Must sample adequate quantity of air to be
statistically meaningful.
◦ 80-100 ft3/min
 Must validate growth promotion after exposure of
settle plates (or other plates) for prolonged time
periods.
Monitoring ConsiderationsMonitoring Considerations
Contamination Control
Methods to AchieveMethods to Achieve
CleanlinessCleanliness Positive Pressure / Airflow
◦ Keeps contamination out of the work area
◦ Depends on clean air input
 Filtration
◦ Development of effective filtration revolutionized industry
◦ HEPA (High Efficiency Particulate Air) and ULPA (Ultra Low
Particulate Air) Filters
 Materials Selection
 User Protocols
 Cleaning
Facility DesignFacility Design
 Complete cleanroom created with centralized
air handling or fan filter units
 Keeps entire room clean
 Requires complete gowning, careful materials
and equipment selection to maintain class
 Costly, often unnecessary
Facility DesignFacility Design
 Can use localized clean areas
 Clean Benches: Horizontal and Vertical
Laminar Flow (HLF on left, VLF on right)
Facility designFacility design
 Isolators, Glove boxes provide better protection
from outside contamination
Contamination Control byContamination Control by
LayoutLayout
 Isolation between processes prevents
cross contamination; separate rooms,
air showers, door interlocks
 “Onion” concept: cleanest areas are
inside, have to pass through
successively cleaner areas to reach
these areas
Air Flow & TurbulenceAir Flow & Turbulence
 Most airflow is
turbulent—no clear
relation between
velocity vectors at
different points
•Particles can be trapped in eddies for long time
•Not optimal for contamination control!! Long
path length for contamination to leave the room
Laminar (Unidirectional) AirLaminar (Unidirectional) Air
FlowFlow
 Concept of laminar airflow
 In cleanrooms, often called
uni-directional flow (UDF)
• Ideal for contamination control—shortest path to
sweep particles out of clean areas; complete room air
change in shortest period of time
High level cleanrooms designed for laminar flow in
most areas
Cost means that for most, clean areas are some
combination of laminar and turbulent flow
Not always a simple tradeoff—with turbulent flow,
require higher air velocities, which require larger air
handlers.
UDF More Important forUDF More Important for
Cleaner AreasCleaner Areas
Practical ConsiderationsPractical Considerations
for UDFfor UDF
 Any objects in path of laminar flow will deflect
airflow—this usually results in turbulence;
USER BEHAVIOR HAS LARGE IMPACT
•Most critical for
laminar flow benches
situated in non-clean
areas; not as critical if
located in larger clean
area
Types of ContaminationTypes of Contamination
 Particulate—encompasses most contamination
 Chemical—films, vapors, etc.
 Biological—bacteria, viruses, etc.; for our
purposes, treat as particles
 Similar concerns for rooms & equipment as for
substrates
Airborne ContaminationAirborne Contamination
From Cleanrooms
Magazine, 2000
Invisible to naked
eye below ~50um
without special
illumination
Particulate ContaminationParticulate Contamination
 Biggest concern for LCI cleanroom users
 Basis for classification of cleanrooms
 Does include biological contamination as a
subset of total particulates
 Many sources: personnel, equipment, etc.
Microbial ContaminationMicrobial Contamination
 Outer layer of human skin can host up to 1
million microorganisms per square cm
 Human saliva up to 1 billion per mL
 Bacteria is usually primary concern, but foreign
organic matter, viruses, fungi, algae are all
included here
 Cross contamination can be a big problem.
ContaminationContamination
MeasurementMeasurement
 Particulate contamination typically measured
with laser particle counter
 Microbial contamination can be measured in
several ways
◦ Centrifugal sampler
◦ Settle plate method
◦ Contact plate method
◦ Swabbing
Usage of MeasurementsUsage of Measurements
 Complementary to yield tracking
 Can use measurements to isolate problem
areas
 Regular measurements can help to track
changes, which can then be tied back to
protocol, personnel, or material changes
◦ Don’t depend upon room to maintain itself.
RealityReality
 In a perfect world, could monitor many points
on a very regular basis
 In reality, this is usually not practical, due to
personnel time and financial constraints
 Important to identify a realistic test &
measurement program
Contamination Control andContamination Control and
Its RelationshipsIts Relationships
 All sources of contamination and control are
interrelated
CleaningCleaning
 Critical to remove contaminants that cannot be
removed by air handling
 Important to follow procedures appropriate to
your application
 What is appropriate for one industry may not
be appropriate for another
 Most important thing is to develop standard
procedures and FOLLOW THEM
Surfaces are importantSurfaces are important
 The efficiency of these cleaning methods
depends on the surface being cleaned
 Rough or pitted surfaces are more difficult to
clean
 Sharp corners are difficult to clean
 That’s why inside surfaces of clean rooms are
smooth.
VacuumingVacuuming
 Dry and wet
◦ Dry has low (<25% ) efficiency for particles smaller
than 10 microns (about .0005 inches)
◦ wet uses liquids which result in greater force on the
particles and hence better cleaning
Wet wipingWet wiping
 Can be very efficient
 Liquid breaks some bonds between surface
and particles and allows particles to float off
 Those adhering on surface can be rubbed off
and retained in wiper.
 Must be careful not to redeposit particles
 Efficiency varies
Tacky rollersTacky rollers
 Efficiency depends of tackiness of roller,
cleanliness of tacky surface and softness of
roller are also very important
Cleaning liquidsCleaning liquids
 No ideal cleaning liquid
 Most facilities use DI water or isopropyl alcohol
with disinfectant
 Water with surfactant and disinfectant may be
used as well as alcohol-water solutions
 The choice depends on what works, cost,
history, etc.
Materials SelectionMaterials Selection
 Choice of materials for supplies, equipment,
gowning, etc. is important
 “Clean” materials can become dirty!!
 Look for easy-to-clean materials
 Triboelectricity can cause static problems, as
can low humidity—this exacerbates
contamination problems
 Biofilms!!
General RequirementsGeneral Requirements
 Minimize sources of contaminants
◦ No smoking
◦ No cosmetics
◦ Avoid high particulate clothing, such as wool
sweaters
◦ Cover up! Uncovered skin can lead to more
contamination
Manufacturing of Aseptically Prepared Products

Mais conteúdo relacionado

Mais procurados

Sanitization & Hygiene in Pharmaceutical
Sanitization & Hygiene in PharmaceuticalSanitization & Hygiene in Pharmaceutical
Sanitization & Hygiene in PharmaceuticalIqra Shafeeq
 
pharmaceutical clean room
pharmaceutical clean room pharmaceutical clean room
pharmaceutical clean room Kiran Thakur
 
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage FormsIn Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage FormsSagar Savale
 
Aseptic processing operation
Aseptic processing operationAseptic processing operation
Aseptic processing operationSai Datri Arige
 
Dipti cleaning ppt
Dipti cleaning pptDipti cleaning ppt
Dipti cleaning pptNeha Suresh
 
Gowning in the pharmaceutical industry
Gowning in the pharmaceutical industry Gowning in the pharmaceutical industry
Gowning in the pharmaceutical industry Jony Mallik
 
Stability of packaging in pharmacy
Stability of packaging in pharmacyStability of packaging in pharmacy
Stability of packaging in pharmacyRahul Pandit
 
Aseptic Process Operation.pptx
Aseptic Process Operation.pptxAseptic Process Operation.pptx
Aseptic Process Operation.pptxObyDulla1
 
Personal Hygiene for pharma industry-Dr. A. Amsavel
Personal Hygiene for pharma industry-Dr. A. AmsavelPersonal Hygiene for pharma industry-Dr. A. Amsavel
Personal Hygiene for pharma industry-Dr. A. AmsavelDr. Amsavel A
 
Advanced sterile product manufacturing technology
Advanced sterile product manufacturing technologyAdvanced sterile product manufacturing technology
Advanced sterile product manufacturing technologyPriyankaSananse
 
Sterile process validation
Sterile process validationSterile process validation
Sterile process validationSagar Savale
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validationVinay Jain
 
Gmp premises 112070804006
Gmp premises 112070804006Gmp premises 112070804006
Gmp premises 112070804006Patel Parth
 
Container and closure for pharmaceutical
Container and closure for pharmaceuticalContainer and closure for pharmaceutical
Container and closure for pharmaceuticalAshvin Bhoge
 
Improved tablet production
Improved tablet productionImproved tablet production
Improved tablet productionceutics1315
 

Mais procurados (20)

Sanitization & Hygiene in Pharmaceutical
Sanitization & Hygiene in PharmaceuticalSanitization & Hygiene in Pharmaceutical
Sanitization & Hygiene in Pharmaceutical
 
pharmaceutical clean room
pharmaceutical clean room pharmaceutical clean room
pharmaceutical clean room
 
Process automation with respect to Sterile Products
Process automation with respect to Sterile ProductsProcess automation with respect to Sterile Products
Process automation with respect to Sterile Products
 
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage FormsIn Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
 
Gowning procedure for Pharma Manufacturing Area
Gowning procedure for Pharma Manufacturing AreaGowning procedure for Pharma Manufacturing Area
Gowning procedure for Pharma Manufacturing Area
 
Aseptic processing operation
Aseptic processing operationAseptic processing operation
Aseptic processing operation
 
Ampule filling and_sealing_machine.ppt1
Ampule filling and_sealing_machine.ppt1Ampule filling and_sealing_machine.ppt1
Ampule filling and_sealing_machine.ppt1
 
Line clearance ppt
Line clearance pptLine clearance ppt
Line clearance ppt
 
Dipti cleaning ppt
Dipti cleaning pptDipti cleaning ppt
Dipti cleaning ppt
 
Gowning in the pharmaceutical industry
Gowning in the pharmaceutical industry Gowning in the pharmaceutical industry
Gowning in the pharmaceutical industry
 
Stability of packaging in pharmacy
Stability of packaging in pharmacyStability of packaging in pharmacy
Stability of packaging in pharmacy
 
Aseptic Process Operation.pptx
Aseptic Process Operation.pptxAseptic Process Operation.pptx
Aseptic Process Operation.pptx
 
Personal Hygiene for pharma industry-Dr. A. Amsavel
Personal Hygiene for pharma industry-Dr. A. AmsavelPersonal Hygiene for pharma industry-Dr. A. Amsavel
Personal Hygiene for pharma industry-Dr. A. Amsavel
 
Air circulation
Air circulationAir circulation
Air circulation
 
Advanced sterile product manufacturing technology
Advanced sterile product manufacturing technologyAdvanced sterile product manufacturing technology
Advanced sterile product manufacturing technology
 
Sterile process validation
Sterile process validationSterile process validation
Sterile process validation
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
 
Gmp premises 112070804006
Gmp premises 112070804006Gmp premises 112070804006
Gmp premises 112070804006
 
Container and closure for pharmaceutical
Container and closure for pharmaceuticalContainer and closure for pharmaceutical
Container and closure for pharmaceutical
 
Improved tablet production
Improved tablet productionImproved tablet production
Improved tablet production
 

Destaque

Destaque (20)

Aseptic processing
Aseptic processingAseptic processing
Aseptic processing
 
Aseptic processing
Aseptic processingAseptic processing
Aseptic processing
 
Aseptic processing
Aseptic processingAseptic processing
Aseptic processing
 
Parenteral production and aseptic area
Parenteral production and aseptic areaParenteral production and aseptic area
Parenteral production and aseptic area
 
Aseptic technique
Aseptic techniqueAseptic technique
Aseptic technique
 
Principles of Aseptic Processing
Principles of Aseptic ProcessingPrinciples of Aseptic Processing
Principles of Aseptic Processing
 
Parenteral preparation, equipments and layout
Parenteral preparation, equipments and layoutParenteral preparation, equipments and layout
Parenteral preparation, equipments and layout
 
Aseptic technique
Aseptic technique Aseptic technique
Aseptic technique
 
Aseptic packaging
Aseptic packagingAseptic packaging
Aseptic packaging
 
Aseptic packaging
Aseptic packagingAseptic packaging
Aseptic packaging
 
Aseptic Packaging
Aseptic PackagingAseptic Packaging
Aseptic Packaging
 
Aseptic packaging
Aseptic packagingAseptic packaging
Aseptic packaging
 
parenterals
parenteralsparenterals
parenterals
 
Aseptic packaging
Aseptic packagingAseptic packaging
Aseptic packaging
 
Aseptic Technique
Aseptic TechniqueAseptic Technique
Aseptic Technique
 
Parenterals
ParenteralsParenterals
Parenterals
 
parenterals....formulation & evaluation
parenterals....formulation & evaluationparenterals....formulation & evaluation
parenterals....formulation & evaluation
 
Storyboard 1 retribution
Storyboard 1   retributionStoryboard 1   retribution
Storyboard 1 retribution
 
How to perform air quality testing
How to perform air quality testingHow to perform air quality testing
How to perform air quality testing
 
Environmental Monitoring - Glove Fingertip Sampling
Environmental Monitoring - Glove Fingertip SamplingEnvironmental Monitoring - Glove Fingertip Sampling
Environmental Monitoring - Glove Fingertip Sampling
 

Semelhante a Manufacturing of Aseptically Prepared Products

Aseptic processing
Aseptic processingAseptic processing
Aseptic processingRiyaRYadav
 
Aseptic Technique for sterile area .pptx
Aseptic Technique for sterile area .pptxAseptic Technique for sterile area .pptx
Aseptic Technique for sterile area .pptxNaeemSarwar37
 
cGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptxcGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptxzohaibmaqsoodneutrop
 
Aseptic processing
Aseptic processingAseptic processing
Aseptic processingdeepakiitbhu
 
Sterile Production Pharmaceuticals.pptx
Sterile Production Pharmaceuticals.pptxSterile Production Pharmaceuticals.pptx
Sterile Production Pharmaceuticals.pptxChittaranjan Das
 
Sediaan steril [compatibility mode](1)
Sediaan steril [compatibility mode](1)Sediaan steril [compatibility mode](1)
Sediaan steril [compatibility mode](1)Eka Selvina
 
Sterilepharmaceuticalproduct
SterilepharmaceuticalproductSterilepharmaceuticalproduct
SterilepharmaceuticalproductMrs. Bhakti Mali
 
Auditing of sterile poduction
Auditing of sterile poductionAuditing of sterile poduction
Auditing of sterile poductionprakhar rai pk
 
Clean rooms in Injectables
Clean rooms in InjectablesClean rooms in Injectables
Clean rooms in InjectablesDr. Jigar Vyas
 
2-1_2-2_AsepticProcessing.ppt
2-1_2-2_AsepticProcessing.ppt2-1_2-2_AsepticProcessing.ppt
2-1_2-2_AsepticProcessing.pptbinhamid2
 
Manufacturing operation and controls
Manufacturing operation and controls Manufacturing operation and controls
Manufacturing operation and controls sachin pawar
 

Semelhante a Manufacturing of Aseptically Prepared Products (20)

Aseptic processing
Aseptic processingAseptic processing
Aseptic processing
 
Aseptic Technique for sterile area .pptx
Aseptic Technique for sterile area .pptxAseptic Technique for sterile area .pptx
Aseptic Technique for sterile area .pptx
 
cGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptxcGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptx
 
Aseptic processing
Aseptic processingAseptic processing
Aseptic processing
 
WHO_Sterile Products.ppt
WHO_Sterile Products.pptWHO_Sterile Products.ppt
WHO_Sterile Products.ppt
 
Gmp premicses
Gmp premicses Gmp premicses
Gmp premicses
 
Manufacturing facility of parentarals as per schedule m
Manufacturing facility of parentarals as per schedule mManufacturing facility of parentarals as per schedule m
Manufacturing facility of parentarals as per schedule m
 
STERILE Prpn.pptx
STERILE Prpn.pptxSTERILE Prpn.pptx
STERILE Prpn.pptx
 
opthalmics.pptx
opthalmics.pptxopthalmics.pptx
opthalmics.pptx
 
Sterile Production Pharmaceuticals.pptx
Sterile Production Pharmaceuticals.pptxSterile Production Pharmaceuticals.pptx
Sterile Production Pharmaceuticals.pptx
 
Shedule m
Shedule mShedule m
Shedule m
 
Sediaan steril [compatibility mode](1)
Sediaan steril [compatibility mode](1)Sediaan steril [compatibility mode](1)
Sediaan steril [compatibility mode](1)
 
Sterilepharmaceuticalproduct
SterilepharmaceuticalproductSterilepharmaceuticalproduct
Sterilepharmaceuticalproduct
 
Auditing of sterile poduction
Auditing of sterile poductionAuditing of sterile poduction
Auditing of sterile poduction
 
Clean rooms in Injectables
Clean rooms in InjectablesClean rooms in Injectables
Clean rooms in Injectables
 
M03_A(1).ppt
M03_A(1).pptM03_A(1).ppt
M03_A(1).ppt
 
2-1_2-2_AsepticProcessing.ppt
2-1_2-2_AsepticProcessing.ppt2-1_2-2_AsepticProcessing.ppt
2-1_2-2_AsepticProcessing.ppt
 
Presentation22.ppt
Presentation22.pptPresentation22.ppt
Presentation22.ppt
 
UNIT II BP606T.pptx
UNIT II BP606T.pptxUNIT II BP606T.pptx
UNIT II BP606T.pptx
 
Manufacturing operation and controls
Manufacturing operation and controls Manufacturing operation and controls
Manufacturing operation and controls
 

Mais de Sunil Boreddy Rx

Mais de Sunil Boreddy Rx (20)

Swine flu
Swine fluSwine flu
Swine flu
 
Semi solid dosage form
Semi solid dosage formSemi solid dosage form
Semi solid dosage form
 
Ria2
Ria2Ria2
Ria2
 
Ria
RiaRia
Ria
 
Ria and elisa
Ria and elisaRia and elisa
Ria and elisa
 
Resealed erythrocytes
Resealed erythrocytesResealed erythrocytes
Resealed erythrocytes
 
Propellents
PropellentsPropellents
Propellents
 
Preformulation
PreformulationPreformulation
Preformulation
 
Preformulation testing of solid dosage forms
Preformulation testing of solid dosage formsPreformulation testing of solid dosage forms
Preformulation testing of solid dosage forms
 
Post approval of drugs
Post approval of drugsPost approval of drugs
Post approval of drugs
 
Pilot plant scaleup techniques used in pharmaceutical manufacturing
Pilot plant scaleup techniques used in pharmaceutical manufacturingPilot plant scaleup techniques used in pharmaceutical manufacturing
Pilot plant scaleup techniques used in pharmaceutical manufacturing
 
Pharmacovigilance overview
Pharmacovigilance overviewPharmacovigilance overview
Pharmacovigilance overview
 
Pharmaceutical preformulation's
Pharmaceutical preformulation'sPharmaceutical preformulation's
Pharmaceutical preformulation's
 
Parenteral drug delivery
Parenteral drug deliveryParenteral drug delivery
Parenteral drug delivery
 
Nasal drug delivery system
Nasal drug delivery systemNasal drug delivery system
Nasal drug delivery system
 
Glp & quality assurance
Glp & quality assuranceGlp & quality assurance
Glp & quality assurance
 
Gas chromatography
Gas chromatographyGas chromatography
Gas chromatography
 
Four major immunologic methods
Four major immunologic methodsFour major immunologic methods
Four major immunologic methods
 
Formulation development of semisolid dosage forms
Formulation development of semisolid dosage formsFormulation development of semisolid dosage forms
Formulation development of semisolid dosage forms
 
Drug discovery and development overview
Drug discovery and development overviewDrug discovery and development overview
Drug discovery and development overview
 

Último

Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
PSYCHIATRIC History collection FORMAT.pptx
PSYCHIATRIC   History collection FORMAT.pptxPSYCHIATRIC   History collection FORMAT.pptx
PSYCHIATRIC History collection FORMAT.pptxPoojaSen20
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 

Último (20)

Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
PSYCHIATRIC History collection FORMAT.pptx
PSYCHIATRIC   History collection FORMAT.pptxPSYCHIATRIC   History collection FORMAT.pptx
PSYCHIATRIC History collection FORMAT.pptx
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 

Manufacturing of Aseptically Prepared Products

  • 2.  Certain pharmaceutical products must be sterile ◦ injections, ophthalmic preparations, irrigations solutions, haemodialysis solutions  Two categories of sterile products ◦ those that can be sterilized in final container (terminally sterilized) ◦ those that cannot be terminally sterilized and must be aseptically prepared
  • 3. Aseptic processing  Objective is to maintain the sterility of a product, assembled from sterile components  Operating conditions so as to prevent microbial contamination
  • 4. Objective  To review specific issues relating to the manufacture of aseptically prepared products: ◦ Manufacturing environment  Clean areas  Personnel ◦ Preparation and filtration of solutions ◦ Pre-filtration bioburden ◦ Filter integrity/validation ◦ Equipment/container preparation and sterilization ◦ Filling Process ◦ Validation of aseptic processes ◦ Specific issues relating to Isolators, BFS and Bulk
  • 5. Classification of Clean Areas ◦ Comparison of classifications WHO GMP US 209E US Customary ISO/TC (209) ISO 14644 EEC GMP Grade A M 3.5 Class 100 ISO 5 Grade A Grade B M 3.5 Class 100 ISO 5 Grade B Grade C M 5.5 Class 10 000 ISO 7 Grade C Grade D M 6.5 Class 100 000 ISO 8 Grade D Table 1
  • 6. Classification of Clean Areas ◦ Classified in terms of airborne particles (Table 2) Grade At rest In operation maximum permitted number of particles/m3 0.5 - 5.0 µm > 5 µm 0.5 - 5.0 µm > 5 µ A 3 500 0 3 500 0 B 3 500 0 350 000 2 000 C 350 000 2 000 3 500 000 20 000 D 3 500 000 20 000 not defined not defined “At rest” - production equipment installed and operating “In operation” - Installed equipment functioning in defined operating mode and specified number of personnel present
  • 7. Four grades of clean areas:  Grade D (equivalent to Class 100,000, ISO 8): ◦ Clean area for carrying out less critical stages in manufacture of aseptically prepared products eg. handling of components after washing.  Grade C (equivalent to Class 10,000, ISO 7): ◦ Clean area for carrying out less critical stages in manufacture of aseptically prepared products eg. preparation of solutions to be filtered.  Grade B (equivalent to Class 100, ISO 5): ◦ Background environment for Grade A zone, eg. cleanroom in which laminar flow workstation is housed.
  • 8.  Grade A (equivalent to Class 100 (US Federal Standard 209E), ISO 5 (ISO 14644-1): ◦ Local zone for high risk operations eg. product filling, stopper bowls, open vials, handling sterile materials, aseptic connections, transfer of partially stoppered containers to be lyophilized. ◦ Conditions usually provided by laminar air flow workstation.  Each grade of cleanroom has specifications for viable and non-viable particles ◦ Non-viable particles are defined by the air classification (See Table 2)
  • 9.  Limits for viable particles (microbiological contamination) Grade Air sample (CFU/m3) Settle plates (90mm diameter) (CFU/4hours) Contact plates (55mm diameter) (CFU/plate) Glove print (5 fingers) (CFU/glove) A < 3 < 3 < 3 < 3 B 10 5 5 5 C 100 50 25 - D 200 100 50 - Table 3 – These are average values – Individual settle plates may be exposed for less than 4 hours • Values are for guidance only - not intended to represent specifications • Levels (limits) of detection of microbiological contamination should be established for alert and action purposes and for monitoring trends of air quality in the facility
  • 10. Environmental Monitoring  Physical ◦ Particulate matter ◦ Differential pressures ◦ Air changes, airflow patterns ◦ Clean up time/recovery ◦ Temperature and relative humidity ◦ Airflow velocity
  • 11. Environmental Monitoring - Physical  Particulate matter ◦ Particles significant because they can contaminate and also carry organisms ◦ Critical environment should be measured not more than 30cm from worksite, within airflow and during filling/closing operations ◦ Preferably a remote probe that monitors continuously ◦ Difficulties when process itself generates particles (e.g. powder filling) ◦ Appropriate alert and action limits should be set and corrective actions defined if limits exceeded
  • 12. Environmental Monitoring - Physical  Differential pressures ◦ Positive pressure differential of 10-15 Pascals should be maintained between adjacent rooms of different classification (with door closed) ◦ Most critical area should have the highest pressure ◦ Pressures should be continuously monitored and frequently recorded. ◦ Alarms should sound if pressures deviate ◦ Any deviations should be investigated and effect on environmental quality determined
  • 13. Environmental Monitoring - Physical  Air Changes/Airflow patterns ◦ Air flow over critical areas should be uni-directional (laminar flow) at a velocity sufficient to sweep particles away from filling/closing area ◦ for B, C and D rooms at least 20 changes per hour are ususally required  Clean up time/recovery ◦ Particulate levels for the Grade A “at rest” state should be achieved after a short “clean-up” period of 20 minutes after completion of operations (guidance value) ◦ Particle counts for Grade A “in operation” state should be maintained whenever product or open container is exposed
  • 14. Environmental Monitoring - Physical  Temperature and Relative Humidity ◦ Ambient temperature and humidity should not be uncomfortably high (could cause operators to generate particles) (18°C)  Airflow velocity ◦ Laminar airflow workstation air speed of approx 0.45m/s ± 20% at working position (guidance value)
  • 15. Personnel  Minimum number of personnel in clean areas ◦ especially during aseptic processing  Inspections and controls from outside  Training to all including cleaning and maintenance staff ◦ initial and regular ◦ manufacturing, hygiene, microbiology ◦ should be formally validated and authorized to enter aseptic area  Special cases ◦ supervision in case of outside staff ◦ decontamination procedures (e.g. staff who worked with animal tissue materials)
  • 16. Personnel (2)  High standards of hygiene and cleanliness ◦ should not enter clean rooms if ill or with open wounds  Periodic health checks  No shedding of particles, movement slow and controlled  No introduction of microbiological hazards  No outdoor clothing brought into clean areas, should be clad in factory clothing  Changing and washing procedure  No watches, jewellery and cosmetics  Eye checks if involved in visual inspection
  • 17. Personnel (3)  Clothing of appropriate quality: ◦ Grade D  hair, beard, moustache covered  protective clothing and shoes ◦ Grade C  hair, beard, moustache covered  single or 2-piece suit (covering wrists, high neck), shoes/overshoes  no fibres/particles to be shed ◦ Grade A and B  headgear, beard and moustache covered, masks, gloves  not shedding fibres, and retain particles shed by operators
  • 18. Personnel (4)  Outdoor clothing not in change rooms leading to Grade B and C rooms  Change at every working session, or once a day (if supportive data)  Change gloves and masks at every working session  Frequent disinfection of gloves during operations  Washing of garments – separate laundry facility ◦ No damage, and according to validated procedures (washing and sterilization)  Regular microbiological monitoring of operators
  • 19.  In aseptic processing, each component is individually sterilised, or several components are combined with the resulting mixture sterilized. ◦ Most common is preparation of a solution which is filtered through a sterilizing filter then filled into sterile containers (e.g active and excipients dissolved in Water for Injection) ◦ May involve aseptic compounding of previously sterilized components which is filled into sterile containers ◦ May involve filling of previously sterilized powder  sterilized by dry heat/irradiation  produced from a sterile filtered solution which is then aseptically crystallized and precipitated  requires more handling and manipulation with higher potential for contamination during processing
  • 20. Preparation and Filtration of Solutions  Solutions to be sterile filtered prepared in a Grade C environment  If not to be filtered, preparation should be prepared in a Grade A environment with Grade B background (e.g. ointments, creams, suspensions and emulsions)  Prepared solutions filtered through a sterile 0.22μm (or less) membrane filter into a previously sterilized container ◦ filters remove bacteria and moulds ◦ do not remove all viruses or mycoplasmas  filtration should be carried out under positive pressure
  • 21. Preparation and Filtration of Solutions (2)  consideration should be given to complementing filtration process with some form of heat treatment  Double filter or second filter at point of fill advisable  Fitlers should not shed particles, asbestos containing filters should not be used  Same filter should not be used for more than one day unless validated  If bulk product is stored in sealed vessels, pressure release outlets should have hydrophobic microbial retentive air filters
  • 22. Preparation and Filtration of Solutions (3)  Time limits should be established for each phase of processing, e.g. ◦ maximum period between start of bulk product compounding and sterilization (filtration) ◦ maximum permitted holding time of bulk if held after filtration prior to filling ◦ product exposure on processing line ◦ storage of sterilized containers/components ◦ total time for product filtration to prevent organisms from penetrating filter ◦ maximum time for upstream filters used for clarification or particle removal (can support microbial attachment)
  • 23. Preparation and Filtration of Solutions (4)  Filling of solution may be followed by lyophilization (freeze drying) ◦ stoppers partially seated, product transferred to lyophilizer (Grade A/B conditions) ◦ Release of air/nitrogen into lyophilizer chamber at completion of process should be through sterilizing filter
  • 24. Prefiltration Bioburden (natural microbial load)  Limits should be stated and testing should be carried out on each batch  Frequency may be reduced after satisfactory history is established ◦ and biobuden testing performed on components  Should include action and alert limits (usually differ by a factor of 10) and action taken if limits are exceeded  Limits should reasonably reflect bioburden routinely achieved
  • 25. Prefiltation Bioburden (2)  No defined “maximum” limit but the limit should not exceed the validated retention capability of the filter  Bioburden controls should also be included in “in-process” controls ◦ particularly when product supports microbial growth and/or manufacturing process involves use of culture media  Excessive bioburden can have adverse effect on the quality of the product and cause excessive levels of endotoxins/pyrogens
  • 26. Filter integrity  Filters of 0.22μm or less should be used for filtration of liquids and gasses (if applicable) ◦ filters for gasses that may be used for purging or overlaying of filled containers or to release vacuum in lyphilization chamber  filter intergrity shoud be verified before filtration and confirmed after filtration ◦ bubble point ◦ pressure hold ◦ forward flow  methods are defined by filter manufacturers and limits determined during filter validation
  • 27. Equipment/container preparation and sterilization  All equipment (including lyophilizers) and product containers/closures should be sterilized using validated cycles ◦ same requirements apply for equipment sterilization that apply to terminally sterilized product ◦ particular attention to stoppers - should not be tightly packed as may clump together and affect air removal during vacuum stage of sterilization process ◦ equipment wrapped and loaded to facilitate air removal ◦ particular attention to filters, housings and tubing
  • 28. Equipment/container preparation and sterilization (2)  CIP/SIP processes ◦ particular attention to deadlegs - different orientation requirements for CIP and SIP  heat tunnels often used for sterilization/depyrogenation of glass vials/bottles ◦ usually high temperature for short period of time ◦ need to consider speed of conveyor ◦ validation of depyrogenation (3 logs endotoxin units)  worst case locations ◦ tunnel supplied with HEPA filtered air
  • 29. Equipment/container preparation and sterilization (2)  equipment should be designed to be easily assembled and disassembled, cleaned, sanitised and/or sterilized ◦ equipment should be appropriately cleaned - O-rings and gaskets should be removed to prevent build up of dirt or residues  rinse water should be WFI grade  equipment should be left dry unless sterilized immediately after cleaning (to prevent build up of pyrogens)  washing of glass containers and rubber stoppers should be validated for endotoxin removal  should be defined storage period between sterilization and use (period should be justified)
  • 30. Additional issues specific to Isolator and BFS Technologies  Isolators ◦ Decontamination process requires a 4-6 log reduction of appropriate Biological Indicator (BI) ◦ Minimum 6 log reduction of BI if surface is to be free of viable organisms ◦ Significant focus on glove integrity - daily checks, second pair of gloves inside isolator glove ◦ Traditional aseptic vigilance should be maintained
  • 31.  Blow-Fill-Seal (BFS) ◦ Located in a Grade D environment ◦ Critial zone should meet Grade A (microbiological) requirements (particle count requirements may be difficult to meet in operation) ◦ Operators meet Grade C garment requirements ◦ Validation of extrusion process should demonstrate destruction of endotoxin and spore challenges in the polymeric material ◦ Final inspection should be capable of detecting leakers
  • 32.  Issues relating to Aseptic Bulk Processing • Applies to products which can not be filtered at point of fill and require aseptic processing throughout entire manufacturing process. • Entire aseptic process should be subject to process simulation studies under worst case conditions (maximum duration of "open" operations, maximum no of operators) • Process simulations should incorporate storage and transport of bulk. • Multiple uses of the same bulk with storage in between should also be included in process simulations • Assurance of bulk vessel integrity for specified holding times.
  • 33.  Bulk Processing (2) • Process simulation for formulation stage should be performed at least twice per year. ◦ Cellular therapies, cell derived products etc  products released before results of sterility tests known (also TPNs, radioactive preps, cytotoxics)  should be manufactured in a closed system  Additional testing  sterility testing of intermediates  microscopic examination (e.g. gram stain)  endotoxin testing
  • 35.  Airborne nonviable particulate monitoring  Airborne viable contaminant monitoring  Viable contaminant monitoring of surfaces  Viable contaminant monitoring of personnel  Temperature and humidity monitoring  Pressure differential monitoring Environmental MonitoringEnvironmental Monitoring ComponentsComponents
  • 36.  Water monitoring: ◦ Total organic carbon ◦ Conductivity ◦ Microbial Contaminants ◦ Endotoxin Environmental MonitoringEnvironmental Monitoring ComponentsComponents
  • 37.  Monitoring frequencies and strategies ◦ Establishment of a meaningful and manageable program  Sampling and testing procedures  Establishment of effective alert and action limits  Trending of results General EnvironmentalGeneral Environmental Monitoring ConsiderationsMonitoring Considerations
  • 38.  Investigation and evaluation of trends as well as excursions from alert and action limits  Corrective actions to be implemented in response to environmental monitoring excursions  Personnel training - sampling, testing, investigating excursions, aseptic technique General EnvironmentalGeneral Environmental Monitoring ConsiderationsMonitoring Considerations
  • 39.  Should include monitoring of all environments where products and their components are manufactured ◦ All areas where there is a risk of product contamination  Should include monitoring of all water used for product manufacturing as well as feed water to the final water purification system (WFI System) Scope of EnvironmentalScope of Environmental Monitoring ProgramMonitoring Program
  • 40.  CFR GMP regulations  FDA Guidance Documents  USP Informational Chapter Regulatory Basis forRegulatory Basis for Environmental MonitoringEnvironmental Monitoring ProgramProgram
  • 41.  Aseptic processing areas: ◦ Easy to clean and maintain ◦ Temperature and humidity controlled ◦ HEPA filtered air ◦ Environmental monitoring system ◦ Cleaning and disinfecting procedures ◦ Scheduled equipment maintenance and calibration 21 CFR 211.4221 CFR 211.42
  • 42.  Ventilation, air filtration, air heating and cooling: ◦ Adequate control over microorganisms, dust, humidity and temperature. ◦ Air filtration systems including prefilters and particulate matter air filters for air supplies to production areas. 21 CFR 211.4621 CFR 211.46
  • 43.  Defines critical and controlled manufacturing areas  Recommends airborne nonviable and viable contaminant limits  Provides some guidance on monitoring frequencies for critical areas Guideline on Sterile DrugGuideline on Sterile Drug Products Produced by AsepticProducts Produced by Aseptic ProcessingProcessing
  • 44.  Recommendations for air pressure differentials  Includes guidance on aseptic media fills  Note: This guidance document was written in 1987 and is in need of revision Guideline on Sterile DrugGuideline on Sterile Drug Products Produced by AsepticProducts Produced by Aseptic ProcessingProcessing
  • 45.  USP General Information Chapter <1116>  Establishment of clean room classifications ◦ Federal Standard 209E  Importance of EM program  Personnel training in aseptic processing  Establishment of sampling plans and sites ◦ suggested sampling frequencies Microbial Evaluation andMicrobial Evaluation and Classification of Clean Rooms andClassification of Clean Rooms and Clean ZonesClean Zones
  • 46.  Establishment of alert and action limits  Suggests limits for airborne, surface and personnel contaminant levels.  Methods and equipment for sampling  Identification of isolates  Aseptic media fills  Emerging technologies - barrier; isolator Microbial Evaluation andMicrobial Evaluation and Classification of Clean Rooms andClassification of Clean Rooms and Clean ZonesClean Zones
  • 47.  “Airborne Particulate Cleanliness Classes in Clean Rooms and Clean Zones  Approved by the GSA for use by all Federal Agencies  Frequently referenced for controlled environment particulate requirements: Classes 100, 10,000 and 100,000 (based on particles > 0.5µ) Federal Standard 209EFederal Standard 209E
  • 48.  Scope limited to final drug product manufacturing and data required for application submission (NDA, BLA)  Requests information on: ◦ Buildings and facilities ◦ Manufacturing operations for drug product  Filter validation  Validation of hold times Guidance for Industry for Sterile ValidationGuidance for Industry for Sterile Validation Process Validation in Applications for HumanProcess Validation in Applications for Human and Veterinary Drug Productsand Veterinary Drug Products
  • 49.  Requests information on: ◦ Sterilization and depyrogenation ◦ Media fills and actions taken when they fail ◦ Microbiological monitoring of the environment  Airborne microorganisms, personnel, surfaces, water system, product component bioburden ◦ Yeasts, molds, anaerobes ◦ Exceeded EM limits Guidance for Industry for Sterile ValidationGuidance for Industry for Sterile Validation Process Validation in Applications for HumanProcess Validation in Applications for Human and Veterinary Drug Productsand Veterinary Drug Products
  • 50. Viable and NonviableViable and Nonviable Contaminant LimitsContaminant Limits Classifi- cation Nonviable (>0.5µ) Viable ft3 m3 ft3 m3 Class 100 100 3,530 0.1 3.5 Class 10,000 10,000 353,000 0.5 18 Class 100,000 100,000 3,530,000 2.5 88
  • 51.  Preparation or manufacturing area where nonsterile product, in-process materials and product-contact equipment surfaces, containers and closures are exposed to the environment  Control nonviable and viable contaminants to reduce product /process bioburden  Class 100,000 or Class 10,000 Controlled AreaControlled Area
  • 52.  Capping areas are now considered controlled manufacturing areas ◦ Should be supplied with HEPA filtered air ◦ Should meet class 100,000 conditions during static conditions Controlled AreaControlled Area
  • 53.  Aseptic processing area where sterile products, components or in-process products are exposed to the environment and no further processing will occur.  Air quality must be Class 100 during processing  Local Class 100 areas are often utilized during open processing steps during drug substance manufacture. Critical AreaCritical Area
  • 54.  The area just preceding the sterile core should be one classification higher than the core. Critical AreaCritical Area
  • 55.  Airborne cleanliness classifications should be met during operations  Nonviable monitoring should occur routinely during operations  Monitoring during static conditions is done as part of HVAC qualification and may be done periodically after that to insure area meets acceptable conditions before use or following cleaning Nonviable Particulate MonitoringNonviable Particulate Monitoring
  • 56.  Locations for monitoring should be established during performance qualification; probes placed close to work surface  Monitoring frequencies vary: ◦ For aseptic processing areas, during each use ◦ For other, controlled areas, varies from each use to weekly or less depending on use of area Nonviable Particulate MonitoringNonviable Particulate Monitoring
  • 57.  HVAC Validation and Maintenance Considerations: ◦ Air velocity, airflow patterns and turbulence should be validated; smoke studies to determine flow patterns during static and dynamic conditions ◦ HEPA filter integrity testing ◦ HEPA filter efficiency testing ◦ Air pressure differentials Nonviable Particulate MonitoringNonviable Particulate Monitoring
  • 58.  Airborne viable contaminants  Surface contaminants ◦ walls ◦ equipment surfaces ◦ countertops ◦ floors  Personnel contaminants Microbial MonitoringMicrobial Monitoring
  • 59.  Monitoring methods should be capable of detecting molds and yeasts  Should also be able to detect anaerobes ◦ Most often, this is an issue associated with products filled anaerobically (with nitrogen overlay)  All lots of media for EM sampling should be growth promotion tested Microbial MonitoringMicrobial Monitoring
  • 60.  Routine microbial monitoring should take place during operations (for airborne contaminants) and immediately following operations (for surfaces and personnel).  Airborne monitoring frequencies: ◦ Each use for aseptic processing areas ◦ Varies from daily to weekly to less frequently for controlled areas depending on use Microbial MonitoringMicrobial Monitoring
  • 61.  Personnel and surface monitoring frequencies vary: ◦ Aseptic processing - after every fill ◦ Other controlled areas - varies from daily to weekly or less for surfaces ◦ Personnel monitoring often restricted to aseptic area personnel and personnel working in Class 100 hoods performing tasks such as inoculation Microbial MonitoringMicrobial Monitoring
  • 62.  Monitoring of surfaces and airborne contaminants during rest periods (following cleaning) ◦ Important for confirming adequacy of cleaning procedures ◦ Indicates whether HVAC system is operating properly ◦ NOTE: Disinfectant effectiveness studies also required for cleaning agents used in the facility Microbial MonitoringMicrobial Monitoring
  • 63.  Monitoring frequencies and procedures are influenced by a number of factors: ◦ Stage of manufacturing ◦ “Open” or “closed” manufacturing step ◦ Single or multiple product manufacturing Microbial MonitoringMicrobial Monitoring
  • 64.  Establishment of monitoring locations should be based on performance qualification studies during dynamic conditions ◦ gridding study to determine worst case locations/most meaningful locations  Should also establish common flora - will aid in investigations Microbial MonitoringMicrobial Monitoring
  • 65.  Action limits (for the most part) have been established in a variety of guidance documents  Alert limits ◦ Lower than action limits ◦ Reflect actual historical results under normal processing conditions Setting Alert and ActionSetting Alert and Action LimitsLimits
  • 66.  Alert limits are designed to provide some warning that environmental quality is approaching action limit and allow you time to correct.  Exceeding alert limit triggers a warning response - i.e., alert affected area personnel  Exceeding multiple alerts - triggers action level response Exceeding LimitsExceeding Limits
  • 67.  Action limit excursions require investigations ◦ Speciation of organism(s) ◦ Review batch records from date of excursion ◦ Review other recent EM data (trends) ◦ Review cleaning records ◦ Interview personnel ◦ Product impact - must quarantine until determined Exceeding LimitsExceeding Limits
  • 68.  Excursions from action limits require corrective actions that may include: ◦ More rigorous or additional monitoring ◦ More rigorous cleaning ◦ Retraining of personnel ◦ Procedural changes - change to or addition of disinfection procedures, for example ◦ HVAC maintenance Exceeding LimitsExceeding Limits
  • 69.  The investigation procedures to be followed should be pre-established and included in SOPs  Depending on the outcome of the investigation, corrective actions should be pre-established to the extent possible Investigations and CorrectiveInvestigations and Corrective ActionsActions
  • 70.  Imperative that EM results be linked to product release so that affected products are not released until investigation completed  Material Review Board or equivalent should be consulted prior to releasing product that was potentially affected by adverse environmental conditions Investigations and CorrectiveInvestigations and Corrective ActionsActions
  • 71.  Should trend monitoring results (environmental and water) ◦ Periodic (quarterly or monthly) review by QA and others ◦ Re-evaluation of action and alert limits on an annual basis ◦ This trending information is generally included in the Annual Product Review TrendingTrending
  • 72.  Control of temperature and humidity required for aseptic processing areas ◦ 21 CFR 211.42(c)(10)(ii)  Generally 65°F and 35-50% humidity are average ◦ Too high - Increases personnel shedding ◦ Too low - Increase static electricity Temperature and HumidityTemperature and Humidity
  • 73.  Temperature should be controlled throughout all manufacturing areas  Temperature and humidity should be monitored and controlled in warehouse areas where temperature/humidity sensitive raw materials are stored ◦ If not able to control humidity, need procedure to follow if humidity exceeds limit Temperature and HumidityTemperature and Humidity
  • 74. Water RequirementsWater Requirements Test Potable Water Purified Water WFI TOC none 500 ppb 500 ppb Conduc- tivity none See USP Table Micro. Purity 500 CFU/ml 100 CFU/ml 10 CFU/ 100 ml Endo- Toxin none none 0.25 EU/ml
  • 75.  Water purified by distillation or reverse osmosis  Prepared from water complying with the U.S. EPA National Primary Drinking Water Regulations  Contains no added substance Water For InjectionWater For Injection
  • 76.  Obtained by a suitable process, usually one of the following: ◦ deionization ◦ reverse osmosis ◦ combination Purified WaterPurified Water
  • 77.  Meets National Drinking Water Regulations  40 CFR Part 141  Periodic monitoring in-house as well as periodic certificates from municipality (if applicable) Potable WaterPotable Water
  • 78.  WFI Systems ◦ Microbial quality and endotoxin  Daily system monitoring  Each use point at least weekly ◦ TOC and Conductivity  Weekly system monitoring  can be taken from worst case point (end of loop, return to tank) Water System MonitoringWater System Monitoring
  • 79.  Purified Water Systems ◦ Weekly monitoring of system for:  microbial quality  TOC  conductivity Water System MonitoringWater System Monitoring
  • 80.  WFI ◦ Solvent for preparation of parenteral solutions ◦ Formulation of mammalian cell culture media ◦ Formulation of purification buffers ◦ Final product formulation ◦ Vial and stopper washing ◦ Final rinse for product equipment Water UseWater Use
  • 81.  Purified Water ◦ Preparation of terminally sterilized microbiological media ◦ Initial rinsing/cleaning ◦ Laboratory use ◦ Feed for WFI system Water UseWater Use
  • 82.  Potable Water ◦ Non-product contact uses ◦ Feed for purified water system Water UseWater Use
  • 83.  Slit-to-Agar (STA) - Powered by vacuum, air taken in through a slit below which is a slowly revolving plate.  Sieve impactor - Vacuum draws in air through perforated cover which is impacted onto petri dish containing nutrient agar Microbial Monitoring DevicesMicrobial Monitoring Devices
  • 84.  Centrifugal Sampler - consists of a propeller that pulls a known volume of air into the unit and then propels the air outward to impact on a nutrient agar strip  Sterilizable Microbiological Atrium (SMA)- similar to sieve impactor; cover contains uniformly spaced orifices; vacuum draws in air which is impacted on agar plate Microbial Monitoring DevicesMicrobial Monitoring Devices
  • 85.  Surface Air System Sampler - An integrated unit containing an entry section with an agar contact plate; behind is a motor and turbine that pulls air in through the perforated cover and exhausts it beyond the motor.  Settle plates - qualitative; may be useful in worst case locations Microbial Monitoring DevicesMicrobial Monitoring Devices
  • 86.  Surface contaminant monitoring devices: ◦ Contact Plates - plates filled with nutrient agar; for regular surfaces ◦ Swabs - useful for hard to reach or irregular surfaces; swab placed in suitable diluent and inoculated onto microbiological plate Microbial Monitoring DevicesMicrobial Monitoring Devices
  • 87.  Remote sampling probes - validate use of tubing  Must sample adequate quantity of air to be statistically meaningful. ◦ 80-100 ft3/min  Must validate growth promotion after exposure of settle plates (or other plates) for prolonged time periods. Monitoring ConsiderationsMonitoring Considerations
  • 89. Methods to AchieveMethods to Achieve CleanlinessCleanliness Positive Pressure / Airflow ◦ Keeps contamination out of the work area ◦ Depends on clean air input  Filtration ◦ Development of effective filtration revolutionized industry ◦ HEPA (High Efficiency Particulate Air) and ULPA (Ultra Low Particulate Air) Filters  Materials Selection  User Protocols  Cleaning
  • 90. Facility DesignFacility Design  Complete cleanroom created with centralized air handling or fan filter units  Keeps entire room clean  Requires complete gowning, careful materials and equipment selection to maintain class  Costly, often unnecessary
  • 91. Facility DesignFacility Design  Can use localized clean areas  Clean Benches: Horizontal and Vertical Laminar Flow (HLF on left, VLF on right)
  • 92. Facility designFacility design  Isolators, Glove boxes provide better protection from outside contamination
  • 93. Contamination Control byContamination Control by LayoutLayout  Isolation between processes prevents cross contamination; separate rooms, air showers, door interlocks  “Onion” concept: cleanest areas are inside, have to pass through successively cleaner areas to reach these areas
  • 94.
  • 95. Air Flow & TurbulenceAir Flow & Turbulence  Most airflow is turbulent—no clear relation between velocity vectors at different points •Particles can be trapped in eddies for long time •Not optimal for contamination control!! Long path length for contamination to leave the room
  • 96. Laminar (Unidirectional) AirLaminar (Unidirectional) Air FlowFlow  Concept of laminar airflow  In cleanrooms, often called uni-directional flow (UDF) • Ideal for contamination control—shortest path to sweep particles out of clean areas; complete room air change in shortest period of time
  • 97. High level cleanrooms designed for laminar flow in most areas Cost means that for most, clean areas are some combination of laminar and turbulent flow Not always a simple tradeoff—with turbulent flow, require higher air velocities, which require larger air handlers.
  • 98. UDF More Important forUDF More Important for Cleaner AreasCleaner Areas
  • 99. Practical ConsiderationsPractical Considerations for UDFfor UDF  Any objects in path of laminar flow will deflect airflow—this usually results in turbulence; USER BEHAVIOR HAS LARGE IMPACT •Most critical for laminar flow benches situated in non-clean areas; not as critical if located in larger clean area
  • 100. Types of ContaminationTypes of Contamination  Particulate—encompasses most contamination  Chemical—films, vapors, etc.  Biological—bacteria, viruses, etc.; for our purposes, treat as particles  Similar concerns for rooms & equipment as for substrates
  • 101. Airborne ContaminationAirborne Contamination From Cleanrooms Magazine, 2000 Invisible to naked eye below ~50um without special illumination
  • 102. Particulate ContaminationParticulate Contamination  Biggest concern for LCI cleanroom users  Basis for classification of cleanrooms  Does include biological contamination as a subset of total particulates  Many sources: personnel, equipment, etc.
  • 103. Microbial ContaminationMicrobial Contamination  Outer layer of human skin can host up to 1 million microorganisms per square cm  Human saliva up to 1 billion per mL  Bacteria is usually primary concern, but foreign organic matter, viruses, fungi, algae are all included here  Cross contamination can be a big problem.
  • 104. ContaminationContamination MeasurementMeasurement  Particulate contamination typically measured with laser particle counter  Microbial contamination can be measured in several ways ◦ Centrifugal sampler ◦ Settle plate method ◦ Contact plate method ◦ Swabbing
  • 105. Usage of MeasurementsUsage of Measurements  Complementary to yield tracking  Can use measurements to isolate problem areas  Regular measurements can help to track changes, which can then be tied back to protocol, personnel, or material changes ◦ Don’t depend upon room to maintain itself.
  • 106. RealityReality  In a perfect world, could monitor many points on a very regular basis  In reality, this is usually not practical, due to personnel time and financial constraints  Important to identify a realistic test & measurement program
  • 107. Contamination Control andContamination Control and Its RelationshipsIts Relationships  All sources of contamination and control are interrelated
  • 108. CleaningCleaning  Critical to remove contaminants that cannot be removed by air handling  Important to follow procedures appropriate to your application  What is appropriate for one industry may not be appropriate for another  Most important thing is to develop standard procedures and FOLLOW THEM
  • 109. Surfaces are importantSurfaces are important  The efficiency of these cleaning methods depends on the surface being cleaned  Rough or pitted surfaces are more difficult to clean  Sharp corners are difficult to clean  That’s why inside surfaces of clean rooms are smooth.
  • 110. VacuumingVacuuming  Dry and wet ◦ Dry has low (<25% ) efficiency for particles smaller than 10 microns (about .0005 inches) ◦ wet uses liquids which result in greater force on the particles and hence better cleaning
  • 111. Wet wipingWet wiping  Can be very efficient  Liquid breaks some bonds between surface and particles and allows particles to float off  Those adhering on surface can be rubbed off and retained in wiper.  Must be careful not to redeposit particles  Efficiency varies
  • 112. Tacky rollersTacky rollers  Efficiency depends of tackiness of roller, cleanliness of tacky surface and softness of roller are also very important
  • 113. Cleaning liquidsCleaning liquids  No ideal cleaning liquid  Most facilities use DI water or isopropyl alcohol with disinfectant  Water with surfactant and disinfectant may be used as well as alcohol-water solutions  The choice depends on what works, cost, history, etc.
  • 114. Materials SelectionMaterials Selection  Choice of materials for supplies, equipment, gowning, etc. is important  “Clean” materials can become dirty!!  Look for easy-to-clean materials  Triboelectricity can cause static problems, as can low humidity—this exacerbates contamination problems  Biofilms!!
  • 115. General RequirementsGeneral Requirements  Minimize sources of contaminants ◦ No smoking ◦ No cosmetics ◦ Avoid high particulate clothing, such as wool sweaters ◦ Cover up! Uncovered skin can lead to more contamination

Notas do Editor

  1. Aseptic processing and sterilization by filtration Aseptic processing We have already discussed the fact that terminal sterilization of a product is preferable as it reduces the risk of and provides more assurance of sterility. However, for some types of products, this is not possible. Another method to prepare a sterile products then is to maintain the sterility of a product, assembled from sterile components. All operating conditions should be such to prevent microbial contamination. What do you think are the aspects that require careful attention?
  2. Personnel play an important part in ensuring the quality of manufacture. It is also relevant (perhaps in particular) in the manufacture of sterile products. Only a minimum number of personnel should work in clean areas, especially during aseptic processing. As far as possible, all inspections and controls should be done from outside the production rooms. Training should be given to all including cleaning and maintenance staff, and should include initial and regular training on manufacturing, hygiene, and microbiology. Look at the procedure for training, training program, training material and assessment of the personnel. In special cases, when outside staff have to enter the clean areas, they should be supervised. Remember also the previous discussion on decontamination procedures (e.g. staff who worked with animal tissue materials).
  3. Personnel working in clean areas should maintain high standards of hygiene and cleanliness. They should undergo periodic health checks, wear clothing that do not shed particles, and should take care not to introduce microbiological contaminants in the areas. No outdoor clothing should be brought into clean change rooms. Personnel should follow changing and washing procedures, wear no watches, jewellery and cosmetics
  4. The WHO GMP text specifies the type of clothing that is appropriate for the different grades of rooms.
  5. Garments should be changed at every working session, or once a day (if supportive data exist through validation studies). Gloves and masks should be changes at every working session Personnel should disinfect their gloves frequently during operations to prevent possible introduction of contaminants (micro) into the areas where they work or touch. Arrangements must be in place for the laundering and sterilization of clean-room clothing. This should be carried out in a controlled environment. If fibres are damaged due to inappropriate cleaning or sterilization, an increased risk for contamination may develop as clothing could shed particles. The use of contract laundries for this purpose, requires an audit by the company to ensure that appropriate procedures are in place.